%0 Journal Article %T Maintenance with single agent bevacizumab fails to improve disease-control in metastatic colorectal cancer %A Roselló, Susana %A Borrás, Ricard %A Cervantes, Andrés %J Hepatobiliary Surgery and Nutrition %D 2018 %B 2018 %9 %! Maintenance with single agent bevacizumab fails to improve disease-control in metastatic colorectal cancer %K %X The availability of biologicals, such as anti-EFGR and anti-VEGF antibodies in combination with chemotherapy (ChT), has improved prognosis of metastatic colorectal cancer (mCRC). However, the administration of drug combinations for a prolonged time implies an increased rate of toxicities, which is why some strategies to de-escalate treatment intensity have been studied. %U https://hbsn.amegroups.org/article/view/20900 %V 7 %N 5 %P 395-398 %@ 2304-389X